Detalhe da pesquisa
1.
Performance of SARS-CoV-2 antigen testing in symptomatic and asymptomatic adults: a single-center evaluation.
BMC Infect Dis
; 21(1): 1071, 2021 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34663212
2.
Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days.
Contemp Clin Trials
; 113: 106652, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34896293
3.
The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial.
Contemp Clin Trials
; 119: 106822, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35697146
4.
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial.
JAMA Netw Open
; 5(7): e2220957, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35834252
5.
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization.
Trials
; 22(1): 363, 2021 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34034784